In Hypertension (high blood pressure) Amiur H 2.5mg/25mg Tablet relaxes the blood vessels so that blood can flow more easily around your body. It also eliminates excess water from the body and increases urine output. This maintains balance of electrolytes (like potassium), lowers your blood pressure and reduces your risk of having a stroke, a heart attack, or kidney problems in the future. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should take it regularly as prescribed for this medicine to be most effective, even if you feel better.
It is unsafe to consume alcohol with Amiur H 2.5mg/25mg Tablet.
Amiur H 2.5mg/25mg Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Amiur H 2.5mg/25mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Amiur H 2.5mg/25mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Amiur H 2.5mg/25mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Amiur H 2.5mg/25mg Tablet may be needed. Please consult your doctor. Use of Amiur H 2.5mg/25mg Tablet is not recommended in patients with severe kidney disease.
Amiur H 2.5mg/25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Amiur H 2.5mg/25mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Amiur H 2.5mg/25mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Oaknet Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)